Acute myeloid leukaemia, who
โขDownload as PPT, PDFโข
4 likesโข644 views
AML Follow Atifa Ambreen: Youtube: https://www.youtube.com/channel/UCVTn-4KeMtXKy1h3_9JbVmw Facebook: https://www.facebook.com/atifaambreen786/ Instagram: https://www.instagram.com/atifa.ambreen/ https://www.instagram.com/invites/contact/?i=1qo1my1nb2qfx&utm_content=kbo8bi7 Snapchat: https://www.snapchat.com/add/atifa.ambreen Twitter: https://twitter.com/atifa_ambreen SUBSCRIBE ... . Email for inquiries: atifa.ambreen@gmail.com
Report
Share
Report
Share
Recommended
Prognostic markers
Prognostic markers are important in hematologic oncology for predicting patient survival, selecting optimal treatment, monitoring treatment response, and detecting relapse. Key prognostic markers in acute myeloid leukemia (AML) include age, white blood cell count, percentage of blasts after treatment, cytogenetics such as inv(16) and t(15;17), mutations such as FLT3 and NPM1, and minimal residual disease levels. The French-American-British classification and World Health Organization classification further categorize AML based on morphology and genetics. Prognosis is favorable in AML subgroups like acute promyelocytic leukemia and those with t(8;21) or inv(16), and adverse with complex
Acute Myelogenous Leukaemia
This document provides an overview of acute myelogenous leukemia (AML). It defines AML, discusses its epidemiology including increasing incidence with age, and reviews its etiology related to environmental/genetic risk factors and predisposing diseases. The document also covers AML classification systems, cytogenetics, clinical features, laboratory findings including blood/bone marrow morphology and immunophenotypes, and general treatment approaches.
medicine.Acute leukemias.(dr.sabir)
Acute leukemias are clonal malignant disorders characterized by the accumulation of immature blast cells in the bone marrow, which replaces normal marrow tissue. This results in bone marrow failure and peripheral blood cytopenias. Acute leukemias are classified as either acute lymphoblastic leukemia (ALL) or acute myeloid leukemia (AML) based on the affected cell lineage. Treatment involves intensive chemotherapy aimed at inducing remission followed by consolidation therapy to eradicate residual leukemia cells. Supportive care is also important to manage complications such as infection during treatment. Long term side effects can include second malignancies, organ dysfunction, and infertility. Prognosis depends on factors like age, white blood cell count, and response to initial
Haematological Malignancies
This document provides information on various types of leukemia and lymphomas. It discusses the classification, presentation, investigations, treatment and prognosis of acute lymphoblastic leukemia, chronic lymphoblastic leukemia, acute myeloid leukemia, chronic myeloid leukemia, chronic lymphocytic leukemia, Hodgkin's lymphoma and non-Hodgkin's lymphoma. Key differences between leukemia and lymphoma are also noted. The document contains detailed information on clinical features, pathogenesis, risk factors and management for each condition.
Leukaemia for bds
Leukaemia is a group of malignant blood disorders affecting the bone marrow and blood-forming tissues. There are four main types classified by whether the affected cells are lymphoid or myeloid, and whether the disease course is acute or chronic. Acute leukemias involve immature blast cells and a rapid progression, while chronic leukemias involve more mature cells and a slower course. The document defines each type and discusses their signs, symptoms, diagnosis, prognostic factors and treatment approaches.
Chronic Myeloid Leukaemia
Chronic myeloid leukemia (CML) is a type of leukemia characterized by the increased and unregulated growth of myeloid cells in the bone marrow. It results from a reciprocal translocation between chromosomes 9 and 22, known as the Philadelphia chromosome, which generates the BCR-ABL fusion gene. This fusion gene encodes for a constitutively active tyrosine kinase that drives the overproduction of white blood cells. CML progresses through chronic, accelerated and blast crisis phases and can be diagnosed by blood and bone marrow tests and identification of the Philadelphia chromosome. Treatment involves tyrosine kinase inhibitors like imatinib, dasatinib or nilotinib, stem cell transplant, or other drugs and monitoring response based on blood counts
Acute myeloid leukemia
This document provides information on Acute Myeloid Leukemia (AML), including:
- AML is a stem cell disorder characterized by a block in differentiation of myeloid precursors.
- It has several predisposing factors such as Down syndrome and exposure to radiation or chemicals.
- Diagnosis involves evaluation of blood counts, identification of blasts in blood and bone marrow, immunophenotyping of blasts, and cytogenetic/molecular testing.
- Several classification systems exist including the French-American-British (FAB) system and the current World Health Organization (WHO) system.
Acute Myeloid Leukemia
This document discusses acute myeloid leukemia (AML) and its acute complications. It defines AML as a clonal expansion of myeloid precursor cells with reduced capacity to differentiate. Common clinical presentations include fever, bleeding, and fatigue due to excessive proliferation of myeloid cells in the bone marrow leading to pancytopenia. Two major acute complications discussed are leukostasis, which can cause pulmonary and neurological symptoms, and tumor lysis syndrome, which results in electrolyte abnormalities and renal impairment.
Recommended
Prognostic markers
Prognostic markers are important in hematologic oncology for predicting patient survival, selecting optimal treatment, monitoring treatment response, and detecting relapse. Key prognostic markers in acute myeloid leukemia (AML) include age, white blood cell count, percentage of blasts after treatment, cytogenetics such as inv(16) and t(15;17), mutations such as FLT3 and NPM1, and minimal residual disease levels. The French-American-British classification and World Health Organization classification further categorize AML based on morphology and genetics. Prognosis is favorable in AML subgroups like acute promyelocytic leukemia and those with t(8;21) or inv(16), and adverse with complex
Acute Myelogenous Leukaemia
This document provides an overview of acute myelogenous leukemia (AML). It defines AML, discusses its epidemiology including increasing incidence with age, and reviews its etiology related to environmental/genetic risk factors and predisposing diseases. The document also covers AML classification systems, cytogenetics, clinical features, laboratory findings including blood/bone marrow morphology and immunophenotypes, and general treatment approaches.
medicine.Acute leukemias.(dr.sabir)
Acute leukemias are clonal malignant disorders characterized by the accumulation of immature blast cells in the bone marrow, which replaces normal marrow tissue. This results in bone marrow failure and peripheral blood cytopenias. Acute leukemias are classified as either acute lymphoblastic leukemia (ALL) or acute myeloid leukemia (AML) based on the affected cell lineage. Treatment involves intensive chemotherapy aimed at inducing remission followed by consolidation therapy to eradicate residual leukemia cells. Supportive care is also important to manage complications such as infection during treatment. Long term side effects can include second malignancies, organ dysfunction, and infertility. Prognosis depends on factors like age, white blood cell count, and response to initial
Haematological Malignancies
This document provides information on various types of leukemia and lymphomas. It discusses the classification, presentation, investigations, treatment and prognosis of acute lymphoblastic leukemia, chronic lymphoblastic leukemia, acute myeloid leukemia, chronic myeloid leukemia, chronic lymphocytic leukemia, Hodgkin's lymphoma and non-Hodgkin's lymphoma. Key differences between leukemia and lymphoma are also noted. The document contains detailed information on clinical features, pathogenesis, risk factors and management for each condition.
Leukaemia for bds
Leukaemia is a group of malignant blood disorders affecting the bone marrow and blood-forming tissues. There are four main types classified by whether the affected cells are lymphoid or myeloid, and whether the disease course is acute or chronic. Acute leukemias involve immature blast cells and a rapid progression, while chronic leukemias involve more mature cells and a slower course. The document defines each type and discusses their signs, symptoms, diagnosis, prognostic factors and treatment approaches.
Chronic Myeloid Leukaemia
Chronic myeloid leukemia (CML) is a type of leukemia characterized by the increased and unregulated growth of myeloid cells in the bone marrow. It results from a reciprocal translocation between chromosomes 9 and 22, known as the Philadelphia chromosome, which generates the BCR-ABL fusion gene. This fusion gene encodes for a constitutively active tyrosine kinase that drives the overproduction of white blood cells. CML progresses through chronic, accelerated and blast crisis phases and can be diagnosed by blood and bone marrow tests and identification of the Philadelphia chromosome. Treatment involves tyrosine kinase inhibitors like imatinib, dasatinib or nilotinib, stem cell transplant, or other drugs and monitoring response based on blood counts
Acute myeloid leukemia
This document provides information on Acute Myeloid Leukemia (AML), including:
- AML is a stem cell disorder characterized by a block in differentiation of myeloid precursors.
- It has several predisposing factors such as Down syndrome and exposure to radiation or chemicals.
- Diagnosis involves evaluation of blood counts, identification of blasts in blood and bone marrow, immunophenotyping of blasts, and cytogenetic/molecular testing.
- Several classification systems exist including the French-American-British (FAB) system and the current World Health Organization (WHO) system.
Acute Myeloid Leukemia
This document discusses acute myeloid leukemia (AML) and its acute complications. It defines AML as a clonal expansion of myeloid precursor cells with reduced capacity to differentiate. Common clinical presentations include fever, bleeding, and fatigue due to excessive proliferation of myeloid cells in the bone marrow leading to pancytopenia. Two major acute complications discussed are leukostasis, which can cause pulmonary and neurological symptoms, and tumor lysis syndrome, which results in electrolyte abnormalities and renal impairment.
prognosticmarkers-reshama-170418164211.pdf
This document discusses prognostic markers in hematologic oncology. It provides an overview of markers for various leukemias and lymphomas to predict patient survival, guide treatment selection and monitoring, and detect relapse. Specific markers are discussed for acute myeloid leukemia (AML), including cytogenetic abnormalities like t(15;17) in acute promyelocytic leukemia (APML), which is responsive to all-trans retinoic acid treatment. Minimal residual disease is also an important prognostic marker that can stratify relapse risk in AML patients.
acute myeloid luekemia: Dr Arun Haldia
1) The document discusses Acute Myeloid Leukemia (AML), including its classification, epidemiology, etiology, clinical presentation, laboratory findings, and specific subtypes defined by genetic abnormalities such as AML with t(8;21), inv(16), and t(15;17).
2) It describes the key features of different AML subtypes including their morphology, immunophenotype, genetics, and prognosis. Specific attention is given to abnormal cells, staining patterns, and genetic translocations that characterize each subtype.
3) The FAB and WHO classification systems are introduced and compared, noting the WHO system incorporates immunophenotyping, cytogenetics, and molecular characteristics
Chapter13
This document classifies and describes different types of acute myeloid leukemia (AML) according to the 2008 WHO classification. It divides AML into categories based on genetic abnormalities, disease characteristics, and test results. Specific chromosome translocations and mutations are listed that define different AML subtypes. The tables also outline specialized testing methods like cytochemistry, immunological markers, and genetic analysis that can help diagnose and classify different forms of AML. Prognostic factors are presented that indicate whether a particular AML case carries a favorable, intermediate, or unfavorable outlook.
Cytogenetic analysis in Hematological Malignancies
1. Cytogenetic analysis identifies recurrent chromosomal abnormalities in hematological malignancies that are important for diagnosis, classification, risk stratification, and treatment selection.
2. Specific abnormalities seen in cancers include t(9;22) in CML, t(8;21), t(15;17), and others in AML, and t(4;11) and others in ALL. Abnormalities in MDS include -Y, del(11q), and -7.
3. Cytogenetic testing aids in diagnosis, determining prognosis, assessing treatment response over time, and detecting relapse in diseases like CML, AML, MDS, lymphoma, CLL and MM.
Acute promyelocytic leukemia NCCN LATEST 2014 Guidelines
Acute promyelocytic leukemia (APL) is a distinct subtype of acute myeloid leukemia characterized by a translocation between chromosomes 15 and 17, resulting in the PML-RARฮฑ fusion gene in leukemic cells. This causes life-threatening coagulopathy and differentiation of promyelocytes into neutrophils in response to all-trans retinoic acid (ATRA). Treatment involves ATRA and chemotherapy, with monitoring for differentiation syndrome as a potential complication. Prognosis depends on initial white blood cell count, with high counts associated with worse outcomes.
TTP.ppt
UAEU - CMHS - Hematology-Oncology Course - MMH 302 - HONC 320. Education material for medical students - It cover basic principles of hematology and oncology, including CAR-T and gene editing. It can be used for study and review. It illustrates main principles of hematology and oncology.
Myeloproliferative disorders
The document discusses myeloproliferative disorders (MPDs), which are clonal stem cell disorders characterized by increased blood cell counts and enlarged spleen and bone marrow. It focuses on chronic myeloid leukemia (CML), describing it as a MPD caused by a genetic mutation that results in uncontrolled white blood cell growth. CML progresses through chronic, accelerated, and blast phases, with symptoms ranging from fatigue to organ enlargement. Diagnosis involves blood and bone marrow tests detecting elevated white and platelet counts and the Philadelphia chromosome genetic abnormality associated with CML.
Acute myeloid leukemia
This document summarizes acute myeloid leukemia (AML), a cancer of the myeloid line of blood cells. It discusses key genetic abnormalities in AML, including those involving RUNX1, CBFB, and KIT genes. The RUNX1 and CBFB genes are involved in chromosomal translocations that result in fusion proteins and interfere with normal hematopoiesis. KIT mutations also occur in some cases and activate proliferation and survival pathways. Diagnosis involves blood tests, bone marrow biopsy, and genetic testing to identify specific abnormalities.
Acute Leukemia Cytogenetics
General overview of WHO classification of Acute Leukemia, Genetic abnormalities
Cytogenetics, Immunophenotyping
ACUTE LEUKEMIA CME FINAL............pptx
This document discusses acute leukemia, including its definition, predisposing factors, mechanisms, clinical features, laboratory diagnosis, and WHO classification. Acute leukemia originates from hematopoietic stem cells and is characterized by proliferation of immature blast cells in the bone marrow. It comprises about 50% of leukemic cases and can be either acute lymphoblastic leukemia (ALL) or acute myeloid leukemia (AML). Diagnosis involves morphological examination of blood and bone marrow smears, cytochemistry, immunophenotyping, cytogenetics, and molecular studies to classify it as ALL or AML and identify specific genetic abnormalities. Prognosis and treatment depend on identified risk factors and mutations.
General and Cellular Morphology
Bacteria have a simple cellular structure that allows them to grow and metabolize at a rapid rate. They are typically 0.5-1.0 um in diameter and have a high surface area to volume ratio that facilitates nutrient absorption. Bacterial cells exist in various shapes including spherical, rod-shaped, and helically curved. They also arrange in characteristic patterns depending on the species. The rigid cell wall gives bacteria their shape and allows them to withstand changes in osmotic pressure. Gram positive and Gram negative bacteria have different cell wall structures, with Gram negatives possessing an additional outer membrane. Internal structures include the cytoplasmic membrane, cytoplasm, ribosomes, and genetic material. Some bacteria form resistant endospores or cysts during
Scope of Pharmaceutical microbiology -2021
Microbiology is the study of microscopic organisms and their interactions. It includes bacteria, fungi, algae, protozoa, and viruses. The document discusses several key applications of microbiology in the pharmaceutical field and related industries. Specifically, it notes that microbiology is crucial for (1) developing antimicrobial drugs and ensuring drug therapies target pathogens without harming hosts, (2) producing antibiotics, vaccines, and other pharmaceutical products, and (3) quality control throughout the pharmaceutical manufacturing process to prevent microbial contamination. Microbiology also plays important roles in medical devices, cosmetics, biopharmaceutical testing, cell banks, and environmental monitoring and remediation.
Nomenclature and classification of microorganisms - 2021
This document summarizes the classification and nomenclature of microorganisms. It discusses how microorganisms are classified into taxonomic groups like species, genus, family, order, class, division and kingdom based on their characteristics and genetic relatedness. The three main methods used for bacterial classification are the intuitive method, numerical taxonomy, and genetic relatedness based on DNA comparisons. It also explains the standards for scientific naming of microorganisms, with each species having a single internationally accepted name for clear communication. A key reference for bacterial taxonomy is Bergey's Manual of Systematic Bacteriology.
Allergy and Hypersensitivity
Allergy and Anaphylaxis/Hypersensitivity document discusses:
1. Allergies are immune system disorders caused by hypersensitivity to allergens like foods, pollens, or dusts. Anaphylaxis is a severe, potentially life-threatening allergic reaction affecting multiple body systems.
2. The four types of hypersensitivity reactions are: Type I involves IgE antibodies and causes immediate allergic reactions. Type II involves IgG/IgM antibodies attacking cell surfaces. Type III involves immune complex formation and complement activation causing tissue damage. Type IV is cell-mediated and involves T lymphocytes responding to antigens days later.
3. Anaphylaxis differs from other allergic reactions in affecting multiple
Autoimmunity and Tolerance
The document discusses immunological tolerance and its breakdown which can lead to autoimmunity and autoimmune diseases. It explains the mechanisms of central and peripheral tolerance that normally prevent immune responses against self-antigens. Failure of these tolerance mechanisms can occur through various causes like a breakdown of T cell anergy or loss of regulatory T cells, resulting in an immune response against self-tissues and the development of autoimmune conditions.
Biosafety Levels
This document outlines the four biosafety levels (BSL 1-4) according to the risk posed by pathogens. BSL1 is for low risk agents and requires basic precautions like gloves and disinfection. BSL2 is for agents that cause human disease but effective treatment exists; it requires biosafety cabinets, restricted access, and medical evaluation for accidents. BSL3 is for indigenous or exotic agents that may cause serious disease; it has enhanced containment like vertical laminar hoods, strict access control, and decontamination of wastes. BSL4 is the highest level, for dangerous exotic agents with no treatment, and requires a completely sealed cabinet, positive pressure personnel suits, showers, and specialized waste
Introduction of Biosafety
This document discusses biosafety and biosecurity in laboratories. It defines biosafety as the combination of practices and procedures used to prevent exposure to pathogens and their accidental release. This includes containment principles and technologies. Biosecurity refers to security measures to prevent theft or misuse of pathogens. The document outlines the history of biosafety guidelines and regulations. It emphasizes the importance of training, awareness, and proper equipment and practices for managing biohazard risks to laboratory personnel, the public, and environment.
Antibodies and Types
The document discusses the components of the immune system and the different classes of antibodies. It states that the immune system consists of cellular components like phagocytes and lymphocytes, as well as molecular components like antibodies. It then goes on to describe the five major classes of antibodies - IgM, IgG, IgE, IgD and IgA - and their different functions in the immune response.
Introduction and types of immunity I Pharmaceutical Microbiology
The document discusses immunology, which is the study of the immune system and its functions. It describes the innate and adaptive immune systems. The innate system is non-specific and provides immediate protection through physical and cellular barriers. The adaptive system builds immunity through antibodies and memory cells to mount pathogen-specific responses. Key components include antigens, antibodies, white blood cells, and proteins that signal and complement immune responses.
Morphological and Selective Biochemical characterization of some specimen
This document provides information on four common bacterial identification tests:
1. The catalase test differentiates whether a bacteria produces the enzyme catalase by observing if gas bubbles are produced when bacteria is added to hydrogen peroxide. Staphylococcus is catalase positive and Streptococcus is negative.
2. The coagulase test identifies Staphylococcus aureus by observing if plasma clots due to coagulase production. S. aureus produces free and bound coagulase.
3. The oxidase test detects oxidase production in bacteria like Pseudomonas by observing the development of color when bacteria is added to oxidase reagent.
4. The indole test identifies if bacteria
Fungi/Yeast/Molds
Fungi differ from bacteria in that they have a cell wall composed of chitin rather than peptidoglycan, and a cell membrane containing ergosterol rather than cholesterol. There are two main types of fungi: yeasts, which grow as single cells, and molds, which grow as filaments called hyphae. Many medically important fungi can exist as either molds or yeasts depending on temperature. Fungi reproduce both sexually through spores and asexually through budding or formation of conidia. Host defenses against fungi include intact skin and mucous membranes, as well as cell-mediated immunity and antibodies, though fungi do not produce endotoxins or exotox
Normal Flora
The document discusses the normal flora of various body sites. It defines normal flora as the bacteria and fungi permanently residing on the skin, in the oral cavity, gut, and vagina. While viruses and parasites are usually not considered normal flora, they can be present without causing symptoms. The three major roles of normal flora are: (1) causing disease in immunocompromised individuals, (2) providing colonization resistance against pathogens, and (3) producing vitamins for the host. Specific normal flora are then described for the skin, gut, ears, and nose.
More Related Content
Similar to Acute myeloid leukaemia, who
prognosticmarkers-reshama-170418164211.pdf
This document discusses prognostic markers in hematologic oncology. It provides an overview of markers for various leukemias and lymphomas to predict patient survival, guide treatment selection and monitoring, and detect relapse. Specific markers are discussed for acute myeloid leukemia (AML), including cytogenetic abnormalities like t(15;17) in acute promyelocytic leukemia (APML), which is responsive to all-trans retinoic acid treatment. Minimal residual disease is also an important prognostic marker that can stratify relapse risk in AML patients.
acute myeloid luekemia: Dr Arun Haldia
1) The document discusses Acute Myeloid Leukemia (AML), including its classification, epidemiology, etiology, clinical presentation, laboratory findings, and specific subtypes defined by genetic abnormalities such as AML with t(8;21), inv(16), and t(15;17).
2) It describes the key features of different AML subtypes including their morphology, immunophenotype, genetics, and prognosis. Specific attention is given to abnormal cells, staining patterns, and genetic translocations that characterize each subtype.
3) The FAB and WHO classification systems are introduced and compared, noting the WHO system incorporates immunophenotyping, cytogenetics, and molecular characteristics
Chapter13
This document classifies and describes different types of acute myeloid leukemia (AML) according to the 2008 WHO classification. It divides AML into categories based on genetic abnormalities, disease characteristics, and test results. Specific chromosome translocations and mutations are listed that define different AML subtypes. The tables also outline specialized testing methods like cytochemistry, immunological markers, and genetic analysis that can help diagnose and classify different forms of AML. Prognostic factors are presented that indicate whether a particular AML case carries a favorable, intermediate, or unfavorable outlook.
Cytogenetic analysis in Hematological Malignancies
1. Cytogenetic analysis identifies recurrent chromosomal abnormalities in hematological malignancies that are important for diagnosis, classification, risk stratification, and treatment selection.
2. Specific abnormalities seen in cancers include t(9;22) in CML, t(8;21), t(15;17), and others in AML, and t(4;11) and others in ALL. Abnormalities in MDS include -Y, del(11q), and -7.
3. Cytogenetic testing aids in diagnosis, determining prognosis, assessing treatment response over time, and detecting relapse in diseases like CML, AML, MDS, lymphoma, CLL and MM.
Acute promyelocytic leukemia NCCN LATEST 2014 Guidelines
Acute promyelocytic leukemia (APL) is a distinct subtype of acute myeloid leukemia characterized by a translocation between chromosomes 15 and 17, resulting in the PML-RARฮฑ fusion gene in leukemic cells. This causes life-threatening coagulopathy and differentiation of promyelocytes into neutrophils in response to all-trans retinoic acid (ATRA). Treatment involves ATRA and chemotherapy, with monitoring for differentiation syndrome as a potential complication. Prognosis depends on initial white blood cell count, with high counts associated with worse outcomes.
TTP.ppt
UAEU - CMHS - Hematology-Oncology Course - MMH 302 - HONC 320. Education material for medical students - It cover basic principles of hematology and oncology, including CAR-T and gene editing. It can be used for study and review. It illustrates main principles of hematology and oncology.
Myeloproliferative disorders
The document discusses myeloproliferative disorders (MPDs), which are clonal stem cell disorders characterized by increased blood cell counts and enlarged spleen and bone marrow. It focuses on chronic myeloid leukemia (CML), describing it as a MPD caused by a genetic mutation that results in uncontrolled white blood cell growth. CML progresses through chronic, accelerated, and blast phases, with symptoms ranging from fatigue to organ enlargement. Diagnosis involves blood and bone marrow tests detecting elevated white and platelet counts and the Philadelphia chromosome genetic abnormality associated with CML.
Acute myeloid leukemia
This document summarizes acute myeloid leukemia (AML), a cancer of the myeloid line of blood cells. It discusses key genetic abnormalities in AML, including those involving RUNX1, CBFB, and KIT genes. The RUNX1 and CBFB genes are involved in chromosomal translocations that result in fusion proteins and interfere with normal hematopoiesis. KIT mutations also occur in some cases and activate proliferation and survival pathways. Diagnosis involves blood tests, bone marrow biopsy, and genetic testing to identify specific abnormalities.
Acute Leukemia Cytogenetics
General overview of WHO classification of Acute Leukemia, Genetic abnormalities
Cytogenetics, Immunophenotyping
ACUTE LEUKEMIA CME FINAL............pptx
This document discusses acute leukemia, including its definition, predisposing factors, mechanisms, clinical features, laboratory diagnosis, and WHO classification. Acute leukemia originates from hematopoietic stem cells and is characterized by proliferation of immature blast cells in the bone marrow. It comprises about 50% of leukemic cases and can be either acute lymphoblastic leukemia (ALL) or acute myeloid leukemia (AML). Diagnosis involves morphological examination of blood and bone marrow smears, cytochemistry, immunophenotyping, cytogenetics, and molecular studies to classify it as ALL or AML and identify specific genetic abnormalities. Prognosis and treatment depend on identified risk factors and mutations.
Similar to Acute myeloid leukaemia, who (10)
Cytogenetic analysis in Hematological Malignancies
Cytogenetic analysis in Hematological Malignancies
ย
Acute promyelocytic leukemia NCCN LATEST 2014 Guidelines
Acute promyelocytic leukemia NCCN LATEST 2014 Guidelines
ย
More from Atifa Ambreen
General and Cellular Morphology
Bacteria have a simple cellular structure that allows them to grow and metabolize at a rapid rate. They are typically 0.5-1.0 um in diameter and have a high surface area to volume ratio that facilitates nutrient absorption. Bacterial cells exist in various shapes including spherical, rod-shaped, and helically curved. They also arrange in characteristic patterns depending on the species. The rigid cell wall gives bacteria their shape and allows them to withstand changes in osmotic pressure. Gram positive and Gram negative bacteria have different cell wall structures, with Gram negatives possessing an additional outer membrane. Internal structures include the cytoplasmic membrane, cytoplasm, ribosomes, and genetic material. Some bacteria form resistant endospores or cysts during
Scope of Pharmaceutical microbiology -2021
Microbiology is the study of microscopic organisms and their interactions. It includes bacteria, fungi, algae, protozoa, and viruses. The document discusses several key applications of microbiology in the pharmaceutical field and related industries. Specifically, it notes that microbiology is crucial for (1) developing antimicrobial drugs and ensuring drug therapies target pathogens without harming hosts, (2) producing antibiotics, vaccines, and other pharmaceutical products, and (3) quality control throughout the pharmaceutical manufacturing process to prevent microbial contamination. Microbiology also plays important roles in medical devices, cosmetics, biopharmaceutical testing, cell banks, and environmental monitoring and remediation.
Nomenclature and classification of microorganisms - 2021
This document summarizes the classification and nomenclature of microorganisms. It discusses how microorganisms are classified into taxonomic groups like species, genus, family, order, class, division and kingdom based on their characteristics and genetic relatedness. The three main methods used for bacterial classification are the intuitive method, numerical taxonomy, and genetic relatedness based on DNA comparisons. It also explains the standards for scientific naming of microorganisms, with each species having a single internationally accepted name for clear communication. A key reference for bacterial taxonomy is Bergey's Manual of Systematic Bacteriology.
Allergy and Hypersensitivity
Allergy and Anaphylaxis/Hypersensitivity document discusses:
1. Allergies are immune system disorders caused by hypersensitivity to allergens like foods, pollens, or dusts. Anaphylaxis is a severe, potentially life-threatening allergic reaction affecting multiple body systems.
2. The four types of hypersensitivity reactions are: Type I involves IgE antibodies and causes immediate allergic reactions. Type II involves IgG/IgM antibodies attacking cell surfaces. Type III involves immune complex formation and complement activation causing tissue damage. Type IV is cell-mediated and involves T lymphocytes responding to antigens days later.
3. Anaphylaxis differs from other allergic reactions in affecting multiple
Autoimmunity and Tolerance
The document discusses immunological tolerance and its breakdown which can lead to autoimmunity and autoimmune diseases. It explains the mechanisms of central and peripheral tolerance that normally prevent immune responses against self-antigens. Failure of these tolerance mechanisms can occur through various causes like a breakdown of T cell anergy or loss of regulatory T cells, resulting in an immune response against self-tissues and the development of autoimmune conditions.
Biosafety Levels
This document outlines the four biosafety levels (BSL 1-4) according to the risk posed by pathogens. BSL1 is for low risk agents and requires basic precautions like gloves and disinfection. BSL2 is for agents that cause human disease but effective treatment exists; it requires biosafety cabinets, restricted access, and medical evaluation for accidents. BSL3 is for indigenous or exotic agents that may cause serious disease; it has enhanced containment like vertical laminar hoods, strict access control, and decontamination of wastes. BSL4 is the highest level, for dangerous exotic agents with no treatment, and requires a completely sealed cabinet, positive pressure personnel suits, showers, and specialized waste
Introduction of Biosafety
This document discusses biosafety and biosecurity in laboratories. It defines biosafety as the combination of practices and procedures used to prevent exposure to pathogens and their accidental release. This includes containment principles and technologies. Biosecurity refers to security measures to prevent theft or misuse of pathogens. The document outlines the history of biosafety guidelines and regulations. It emphasizes the importance of training, awareness, and proper equipment and practices for managing biohazard risks to laboratory personnel, the public, and environment.
Antibodies and Types
The document discusses the components of the immune system and the different classes of antibodies. It states that the immune system consists of cellular components like phagocytes and lymphocytes, as well as molecular components like antibodies. It then goes on to describe the five major classes of antibodies - IgM, IgG, IgE, IgD and IgA - and their different functions in the immune response.
Introduction and types of immunity I Pharmaceutical Microbiology
The document discusses immunology, which is the study of the immune system and its functions. It describes the innate and adaptive immune systems. The innate system is non-specific and provides immediate protection through physical and cellular barriers. The adaptive system builds immunity through antibodies and memory cells to mount pathogen-specific responses. Key components include antigens, antibodies, white blood cells, and proteins that signal and complement immune responses.
Morphological and Selective Biochemical characterization of some specimen
This document provides information on four common bacterial identification tests:
1. The catalase test differentiates whether a bacteria produces the enzyme catalase by observing if gas bubbles are produced when bacteria is added to hydrogen peroxide. Staphylococcus is catalase positive and Streptococcus is negative.
2. The coagulase test identifies Staphylococcus aureus by observing if plasma clots due to coagulase production. S. aureus produces free and bound coagulase.
3. The oxidase test detects oxidase production in bacteria like Pseudomonas by observing the development of color when bacteria is added to oxidase reagent.
4. The indole test identifies if bacteria
Fungi/Yeast/Molds
Fungi differ from bacteria in that they have a cell wall composed of chitin rather than peptidoglycan, and a cell membrane containing ergosterol rather than cholesterol. There are two main types of fungi: yeasts, which grow as single cells, and molds, which grow as filaments called hyphae. Many medically important fungi can exist as either molds or yeasts depending on temperature. Fungi reproduce both sexually through spores and asexually through budding or formation of conidia. Host defenses against fungi include intact skin and mucous membranes, as well as cell-mediated immunity and antibodies, though fungi do not produce endotoxins or exotox
Normal Flora
The document discusses the normal flora of various body sites. It defines normal flora as the bacteria and fungi permanently residing on the skin, in the oral cavity, gut, and vagina. While viruses and parasites are usually not considered normal flora, they can be present without causing symptoms. The three major roles of normal flora are: (1) causing disease in immunocompromised individuals, (2) providing colonization resistance against pathogens, and (3) producing vitamins for the host. Specific normal flora are then described for the skin, gut, ears, and nose.
Microbiology of Air, Water and Soil
The document discusses the benefits of exercise for mental health. Regular physical activity can help reduce anxiety and depression and improve mood and cognitive functioning. Exercise causes chemical changes in the brain that may help protect against mental illness and improve symptoms.
Culture media
Culture medium is a substance used to grow microorganisms outside the body. It provides nutrients like carbon, nitrogen, minerals and growth factors. Culture media can be solid, semi-solid or liquid. They are classified as simple, complex, synthetic or special based on ingredients. Special media include enriched media which adds substances like blood or serum, and selective media which uses antibiotics to inhibit certain bacteria. Differential and transport media are also used to identify bacteria or safely transport clinical samples for identification.
Bacterial Culture
This document discusses different culture techniques used to isolate and grow bacteria, including streak culture, lawn culture, stroke culture, stab culture, and pour plate method. Streak culture is used to isolate single colonies on a plate by streaking inoculum in parallel lines. Lawn culture provides uniform surface growth by flooding the plate. Stroke and stab cultures grow bacteria in agar slopes or slants for diagnostic tests or maintaining stock cultures. Pour plate method mixes inoculum into molten agar before pouring to quantify bacterial counts.
An Overview of Immunity to Viruses, Bacteria, Fungi and Ptozoans
This document provides an overview of immunity to various pathogens. It discusses the characteristics of pathogens like viruses, bacteria, fungi and protozoa. It explains that pathogens have developed mechanisms to interact with and exploit hosts, while hosts have innate and adaptive immune responses. It describes the complex life cycles of some pathogens like fungi and protozoa that allow them to evade drug treatments by switching forms. It also explains how viruses are highly dependent on host cell machinery to replicate and produce new virus particles to infect other cells.
An Overview of the Immune System
The document summarizes the three lines of defense of the human immune system:
1) Physical and chemical barriers that protect from pathogens.
2) Nonspecific resistance involving phagocytic cells that ingest and destroy microbes.
3) Specific resistance where antigens activate T cells and B cells to produce antibodies against specific pathogens, utilizing both cell-mediated and antibody-mediated immunity. Memory cells provide lasting protection against future attacks.
Major Histocompatibility Complex (MHC)
The major histocompatibility complex (MHC) is a set of genes that code for cell surface proteins essential for the acquired immune system to recognize foreign molecules in vertebrates. Peptides from intracellular pathogens are carried to the cell surface by MHC class I and MHC class II and presented to CD4 T cells. Antigen presenting cells like dendritic cells, macrophages, and B cells present MHC class II antigens to CD4 T cells, while all nucleated cells present MHC class I antigens.
Factor affecting bacterial growth
The document discusses several factors that affect the growth of bacteria, including nutrition concentration, temperature, pH, ions and salt concentration, gaseous concentration, and available water. It notes that bacterial growth rate increases with increasing nutrient and temperature levels up to an optimal point, but then decreases at very high temperatures. Most bacteria grow best at a neutral pH between 6.5-7.5. Different bacteria have varying requirements for metal ions, oxygen, carbon dioxide, and water availability. Temperature, pH, oxygen levels, and water availability all impact bacterial metabolic and physiological processes.
Cellular and molecular basis of immunity
The document discusses the different classes of antibodies (immunoglobulins) that make up the humoral immune response. It describes the five main classes: IgM, which is the first antibody produced in response to new antigens; IgG, which represents the majority of antibodies in circulation and provides protection at mucosal surfaces; IgE, which binds allergens and triggers histamine release involved in allergic responses; IgD, which functions mainly as an antigen receptor on B cells; and IgA, which is found mainly at mucosal surfaces and provides protection against pathogens.
More from Atifa Ambreen (20)
Nomenclature and classification of microorganisms - 2021
Nomenclature and classification of microorganisms - 2021
ย
Introduction and types of immunity I Pharmaceutical Microbiology
Introduction and types of immunity I Pharmaceutical Microbiology
ย
Morphological and Selective Biochemical characterization of some specimen
Morphological and Selective Biochemical characterization of some specimen
ย
An Overview of Immunity to Viruses, Bacteria, Fungi and Ptozoans
An Overview of Immunity to Viruses, Bacteria, Fungi and Ptozoans
ย
Recently uploaded
Level 3 NCEA - NZ: A Nation In the Making 1872 - 1900 SML.ppt
The History of NZ 1870-1900.
Making of a Nation.
From the NZ Wars to Liberals,
Richard Seddon, George Grey,
Social Laboratory, New Zealand,
Confiscations, Kotahitanga, Kingitanga, Parliament, Suffrage, Repudiation, Economic Change, Agriculture, Gold Mining, Timber, Flax, Sheep, Dairying,
Andreas Schleicher presents PISA 2022 Volume III - Creative Thinking - 18 Jun...
Andreas Schleicher, Director of Education and Skills at the OECD presents at the launch of PISA 2022 Volume III - Creative Minds, Creative Schools on 18 June 2024.
220711130082 Srabanti Bag Internet Resources For Natural Science
Internet resources for natural science
A Visual Guide to 1 Samuel | A Tale of Two Hearts
These slides walk through the story of 1 Samuel. Samuel is the last judge of Israel. The people reject God and want a king. Saul is anointed as the first king, but he is not a good king. David, the shepherd boy is anointed and Saul is envious of him. David shows honor while Saul continues to self destruct.
Diversity Quiz Prelims by Quiz Club, IIT Kanpur
Prelims of Diversity Quiz, conducted by Quiz Club, IIT Kanpur in collaboration with Unmukt on 22 June 2024.
skeleton System.pdf (skeleton system wow)
๐ฅ๐ฅ๐ฅ๐ฅ๐ฅ๐ฅ๐ฅ๐ฅ๐ฅ
โ โุฅุถุบ ุจูู ุฅูุฏููู
โู
ู ุฃููู ุงูู
ูุงุฒู
ุงูุชู ุตู
ู
ุชูุง
ู
ูุฒู
ุฉ ุชุดุฑูุญ ุงูุฌูุงุฒ ุงูููููู (ูุธุฑู 3)
๐๐๐๐๐๐๐๐๐๐
ุชุชู
ูุฒ ูุฐูู ุงูู
ูุฒู
ุฉ ุจุนูุฏุฉ ู
ูู
ูุฒุงุช :
1- ู
ูุชุฑุฌู
ุฉ ุชุฑุฌู
ุฉ ุชููุงุณุจ ุฌู
ูุน ุงูู
ุณุชููุงุช
2- ุชุญุชูู ุนูู 78 ุฑุณู
ุชูุถูุญู ููู ููู
ุฉ ู
ูุฌูุฏุฉ ุจุงูู
ูุฒู
ุฉ (ููู ููู
ุฉ !!!!)
#ููู
_ู
ุงูู_ุฏุฑุฎ
3- ุฏูุฉ ุงููุชุงุจุฉ ูุงูุตูุฑ ุนุงููุฉ ุฌุฏุงู ุฌุฏุงู ุฌุฏุงู
4- ูููุงูู ุจุนุถ ุงูู
ุนููู
ุงุช ุชู
ุชูุถูุญูุง ุจุดูู ุชูุตููู ุฌุฏุงู (ุชูุนุชุจุฑ ูุฏู ุงูุทุงูุจ ุฃู ุงูุทุงูุจุฉ ุจุฅููุง ู
ุนููู
ุงุช ู
ูุจูู
ุฉ ูู
ุน ุฐูู ุชู
ุชูุถูุญ ูุฐูู ุงูู
ุนููู
ุงุช ุงูู
ูุจูู
ุฉ ุจุดูู ุชูุตููู ุฌุฏุงู
5- ุงูู
ูุฒู
ุฉ ุชุดุฑุญ ููุณูุง ุจ ููุณูุง ุจุณ ุชููู ุชุนุงู ุงูุฑุงูู
6- ุชุญุชูู ุงูู
ูุฒู
ุฉ ูู ุงูู ุณูุงูุฏ ุนูู ุฎุงุฑุทุฉ ุชุชุถู
ู ุฌู
ูุน ุชูุฑูุนุงุช ู
ุนููู
ุงุช ุงูุฌูุงุฒ ุงูููููู ุงูู
ุฐููุฑุฉ ูู ูุฐูู ุงูู
ูุฒู
ุฉ
ูุงุฎูุฑุงู ูุฐูู ุงูู
ูุฒู
ุฉ ุญูุงูู ุนูููู
ูุฅุชู
ูู ู
ููู
ุฅู ุชุฏุนููู ุจุงูุฎูุฑ ูุงูุตุญุฉ ูุงูุนุงููุฉ ููุท
ูู ุงูุชูููู ุฒู
ูุงุฆู ูุฒู
ููุงุชู ุ ุฒู
ูููู
ู
ุญู
ุฏ ุงูุฐูุจู ๐๐
๐ฅ๐ฅ๐ฅ๐ฅ๐ฅ๐ฅ๐ฅ๐ฅ๐ฅ
Information and Communication Technology in Education
(๐๐๐ ๐๐๐) (๐๐๐ฌ๐ฌ๐จ๐ง 2)-๐๐ซ๐๐ฅ๐ข๐ฆ๐ฌ
๐๐ฑ๐ฉ๐ฅ๐๐ข๐ง ๐ญ๐ก๐ ๐๐๐ ๐ข๐ง ๐๐๐ฎ๐๐๐ญ๐ข๐จ๐ง:
Students will be able to explain the role and impact of Information and Communication Technology (ICT) in education. They will understand how ICT tools, such as computers, the internet, and educational software, enhance learning and teaching processes. By exploring various ICT applications, students will recognize how these technologies facilitate access to information, improve communication, support collaboration, and enable personalized learning experiences.
๐๐ข๐ฌ๐๐ฎ๐ฌ๐ฌ ๐ญ๐ก๐ ๐ซ๐๐ฅ๐ข๐๐๐ฅ๐ ๐ฌ๐จ๐ฎ๐ซ๐๐๐ฌ ๐จ๐ง ๐ญ๐ก๐ ๐ข๐ง๐ญ๐๐ซ๐ง๐๐ญ:
-Students will be able to discuss what constitutes reliable sources on the internet. They will learn to identify key characteristics of trustworthy information, such as credibility, accuracy, and authority. By examining different types of online sources, students will develop skills to evaluate the reliability of websites and content, ensuring they can distinguish between reputable information and misinformation.
How to Download & Install Module From the Odoo App Store in Odoo 17
Custom modules offer the flexibility to extend Odoo's capabilities, address unique requirements, and optimize workflows to align seamlessly with your organization's processes. By leveraging custom modules, businesses can unlock greater efficiency, productivity, and innovation, empowering them to stay competitive in today's dynamic market landscape. In this tutorial, we'll guide you step by step on how to easily download and install modules from the Odoo App Store.
CapTechTalks Webinar Slides June 2024 Donovan Wright.pptx
Slides from a Capitol Technology University webinar held June 20, 2024. The webinar featured Dr. Donovan Wright, presenting on the Department of Defense Digital Transformation.
ู
ุตุญู ุงููุฑุงุกุงุช ุงูุนุดุฑ ุฃุนุฏ ุฃุญุฑู ุงูุฎูุงู ุณู
ูุฑ ุจุณูููู.pdf
ู
ุตุญู ุงููุฑุงุกุงุช ุงูุนุดุฑ ุฃุนุฏ ุฃุญุฑู ุงูุฎูุงู ุณู
ูุฑ ุจุณูููู.pdfุณู
ูุฑ ุจุณูููู
ู
ุตุญู ุฃุญุฑู ุงูุฎูุงู ูููุฑุงุก ุงูุนุดุฑุฉุฃุนุฏ ุฃุญุฑู ุงูุฎูุงู ุจุงูุชูููู ูุตูุง ุณู
ูุฑ ุจุณูููู ุบูุฑ ุงููู ููย
How to Fix [Errno 98] address already in use
This slide will represent the cause of the error โ[Errno 98] address already in useโ and the troubleshooting steps to resolve this error in Odoo.
Contiguity Of Various Message Forms - Rupam Chandra.pptx
Contiguity Of Various Message Forms - Rupam Chandra.pptx
HYPERTENSION - SLIDE SHARE PRESENTATION.
IT WILL BE HELPFULL FOR THE NUSING STUDENTS
IT FOCUSED ON MEDICAL MANAGEMENT AND NURSING MANAGEMENT.
HIGHLIGHTS ON HEALTH EDUCATION.
BรI TแบฌP Bแป TRแปข TIแบพNG ANH LแปP 8 - Cแบข NฤM - FRIENDS PLUS - NฤM HแปC 2023-2024 (B...
BรI TแบฌP Bแป TRแปข TIแบพNG ANH LแปP 8 - Cแบข NฤM - FRIENDS PLUS - NฤM HแปC 2023-2024 (B...Nguyen Thanh Tu Collection
https://app.box.com/s/nrwz52lilmrw6m5kqeqn83q6vbdp8yzpย
A Free 200-Page eBook ~ Brain and Mind Exercise.pptx
(A Free eBook comprising 3 Sets of Presentation of a selection of Puzzles, Brain Teasers and Thinking Problems to exercise both the mind and the Right and Left Brain. To help keep the mind and brain fit and healthy. Good for both the young and old alike.
Answers are given for all the puzzles and problems.)
With Metta,
Bro. Oh Teik Bin ๐๐ค๐ค๐ฅฐ
Recently uploaded (20)
Level 3 NCEA - NZ: A Nation In the Making 1872 - 1900 SML.ppt
Level 3 NCEA - NZ: A Nation In the Making 1872 - 1900 SML.ppt
ย
Andreas Schleicher presents PISA 2022 Volume III - Creative Thinking - 18 Jun...
Andreas Schleicher presents PISA 2022 Volume III - Creative Thinking - 18 Jun...
ย
220711130082 Srabanti Bag Internet Resources For Natural Science
220711130082 Srabanti Bag Internet Resources For Natural Science
ย
220711130088 Sumi Basak Virtual University EPC 3.pptx
220711130088 Sumi Basak Virtual University EPC 3.pptx
ย
220711130097 Tulip Samanta Concept of Information and Communication Technology
220711130097 Tulip Samanta Concept of Information and Communication Technology
ย
Information and Communication Technology in Education
Information and Communication Technology in Education
ย
How to Download & Install Module From the Odoo App Store in Odoo 17
How to Download & Install Module From the Odoo App Store in Odoo 17
ย
CapTechTalks Webinar Slides June 2024 Donovan Wright.pptx
CapTechTalks Webinar Slides June 2024 Donovan Wright.pptx
ย
ู
ุตุญู ุงููุฑุงุกุงุช ุงูุนุดุฑ ุฃุนุฏ ุฃุญุฑู ุงูุฎูุงู ุณู
ูุฑ ุจุณูููู.pdf
ู
ุตุญู ุงููุฑุงุกุงุช ุงูุนุดุฑ ุฃุนุฏ ุฃุญุฑู ุงูุฎูุงู ุณู
ูุฑ ุจุณูููู.pdf
ย
Contiguity Of Various Message Forms - Rupam Chandra.pptx
Contiguity Of Various Message Forms - Rupam Chandra.pptx
ย
BรI TแบฌP Bแป TRแปข TIแบพNG ANH LแปP 8 - Cแบข NฤM - FRIENDS PLUS - NฤM HแปC 2023-2024 (B...
BรI TแบฌP Bแป TRแปข TIแบพNG ANH LแปP 8 - Cแบข NฤM - FRIENDS PLUS - NฤM HแปC 2023-2024 (B...
ย
A Free 200-Page eBook ~ Brain and Mind Exercise.pptx
A Free 200-Page eBook ~ Brain and Mind Exercise.pptx
ย
Acute myeloid leukaemia, who
- 2. AML with Recurrent GeneticAML with Recurrent Genetic AbnormalitiesAbnormalities ๏ฎ AML with t(8;21) RUNX1-RUNX1T1AML with t(8;21) RUNX1-RUNX1T1 ๏ฎ AML with inv (16) or t(16;16)AML with inv (16) or t(16;16) ๏ฎ Acute promyelocytic leukaemia withAcute promyelocytic leukaemia with t(15;17), PML-RARAt(15;17), PML-RARA ๏ฎ AML with t(9;11), MLLT3-MLLAML with t(9;11), MLLT3-MLL ๏ฎ AML with t(6;9),DEK-NUP214AML with t(6;9),DEK-NUP214 ๏ฎ AML with inv (3)AML with inv (3)
- 3. AML with Recurrent GeneticAML with Recurrent Genetic AbnormalitiesAbnormalities ๏ฎ AML (megakaryoblastic) with t(1;22),AML (megakaryoblastic) with t(1;22), RBM15-MKL1RBM15-MKL1 ๏ฎ AML with mutated NPM1AML with mutated NPM1 ๏ฎ AML with mutated CEBPAAML with mutated CEBPA
- 4. ๏ฎ AML with myelodysplasia relatedAML with myelodysplasia related changes.changes. ๏ฎ Therapy related myeloid neoplasms.Therapy related myeloid neoplasms. ๏ฎ Myeloid sarcoma.Myeloid sarcoma. ๏ฎ Blastic plasmacytoid dendritic cellBlastic plasmacytoid dendritic cell neoplasm.neoplasm.
- 5. ๏ฎ Acute myeloid leukaemia, NOSAcute myeloid leukaemia, NOS ๏ AML with minimal differentiationAML with minimal differentiation ๏ AML without maturationAML without maturation ๏ AML with maturationAML with maturation ๏ Acute myelomonocytic leukaemiaAcute myelomonocytic leukaemia ๏ Acute monoblastic and monocyticAcute monoblastic and monocytic leukaemia.leukaemia.
- 6. ๏ Acute erythroid leukaemiaAcute erythroid leukaemia ๏ Acute megakaryoblastic leukaemiaAcute megakaryoblastic leukaemia ๏ Acute basophilic leukaemiaAcute basophilic leukaemia ๏ Acute panmyelosis with myelofibrosis.Acute panmyelosis with myelofibrosis.
- 7. ๏ฎ Myeloid proliferations related toMyeloid proliferations related to Down syndromeDown syndrome ๏ Transient abnormal myelopoiesisTransient abnormal myelopoiesis ๏ Myeloid leukaemia associated with DownMyeloid leukaemia associated with Down syndromesyndrome